Press release
Acute Respiratory Distress Syndrome (ARDS) Market Size, Growth And Analysis Report 2033
Acute Respiratory Distress Syndrome (ARDS) Market Size
According to The Business Research Company's, the opioids market size has grown steadily in recent years. It will grow from $22.77 billion in 2023 to $23.54 billion in 2024 at a compound annual growth rate (CAGR) of 3.4%. The growth in the historic period can be attributed to pain management, surgical procedures, palliative care, regulatory environment.
The opioids market size is expected to see steady growth in the next few years. It will grow to $26.51 billion in 2028 at a compound annual growth rate (CAGR) of 3.0%. The growth in the forecast period can be attributed to non-cancer pain indications, regulatory changes, telemedicine and remote prescribing, chronic pain management. Major trends in the forecast period include opioid-sparing strategies, medication-assisted treatment (mat), risk mitigation, public health initiatives.
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/acute-respiratory-distress-syndrome-ards-global-market-report
Market Drivers and Trends:
The growing prevalence of pneumonia is expected to propel the growth of the acute respiratory distress syndrome (ARDS) market going forward. Pneumonia is an infection that affects one or both lungs, causing the lungs' air sacs, or alveoli, to fill up with fluid or pus. Pneumonia causes an inflammatory reaction in the lungs, increasing blood vessel permeability and fluid leakage into the alveoli. This fluid buildup interferes with the exchange of oxygen and carbon dioxide, causing respiratory discomfort. For instance, according to the Centers for Disease Control and Prevention, a US-based government agency, in 2021, the number of deaths due to pneumonia in the United States was 41,309, with a mortality rate of 12.4 deaths per 100,000 population. Therefore, the growing prevalence of pneumonia drives the growth of the acute respiratory distress syndrome (ARDS) market.
Major companies operating in the acute respiratory distress syndrome (ARDS) market are focusing on developing innovative drugs and supplements, such as Aviptadil, HSP90 inhibitors and others to sustain their position in the market. Aviptadil is a synthesized vasoactive intestinal peptide (VIP) that binds specifically to receptors on lung alveolar type II cells. For instance, in November 2022, Zuventus Healthcare Ltd., an India-based pharmaceutical manufacturing company, launched Aviptadil to treat acute respiratory distress syndrome. Aviptadil, a vasoactive intestinal peptide supplement, improves breathing and lowers mortality in ARDS patients. This is accomplished through Aviptadil's ability to protect and regenerate Type-2 Pneumocytes, restore Type-1 Pneumocytes, increase surfactant synthesis and suppress IL-6 (interleukin 6) and tumor necrosis factor (TNF)-alpha.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample_request?id=13005&type=smp
Major Key Players of the Market: Johnson & Johnson Services Inc., Novartis AG, GlaxoSmithKline PLC, Medtronic PLC, Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Amgen Inc., Fresenius SE & Co. KGaA, Koninklijke Philips N.V., Baxter International Inc., Teva Pharmaceutical Industries Ltd., CSL Behring, Terumo Corporation, ResMed Inc., Smiths Medical Inc., Dräger Safety AG & Co. KGaA., Getinge AB, Mallinckrodt PLC, Masimo Corporation, United Therapeutics Corporation, Fisher & Paykel Healthcare Corporation Limited, Hamilton Medical AG, Zuventus Healthcare Ltd., Windtree Therapeutics Inc., Faron Pharmaceuticals Oy, AcelRx Pharmaceuticals Inc.
Acute Respiratory Distress Syndrome (ARDS) Market 2024 Key Insights:
• The acute respiratory distress syndrome (ards) is expected to grow to $1.93 billion in 2028 at a compound annual growth rate (CAGR) of 10.7%.
• Impact Of Increasing Pneumonia Prevalence On The Acute Respiratory Distress Syndrome (ARDS) Market
• Increasing Number Of Respiratory Illness Are Anticipated To Positively Impact The Acute Respiratory Distress Syndrome (ARDS) Market
• North America was the largest region in the acute respiratory distress syndrome (ARDS) market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=13005&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Acute Respiratory Distress Syndrome (ARDS) Market Size, Growth And Analysis Report 2033 here
News-ID: 3671792 • Views: …
More Releases from The Business research company
Future of Arachidonic Acid Market: Size, Share & Forecasts to 2029
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What Is the Projected Market Size Valuation of the Arachidonic Acid Market by 2025?
The market scope of arachidonic acid has witnessed significant expansion in the recent past. The valuation will inflate from $5.88 billion in 2024 to $6.31 billion in 2025, marking a compound annual growth rate (CAGR) of 7.3%.…
Solvent-Based Inks Market Analysis: $11.09 Billion by 2029 With a CAGR of 4.5%
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
Solvent-Based Inks Market Value Projection: How Much Will the Market Size by 2025?
In the last few years, there has been a consistent expansion in the solvent-based inks market size. The market, which was worth $8.9 billion in 2024, is projected to escalate to $9.28 billion in 2025 at a compound…
Phosgene Market on Path to Hit $6.25 Billion by 2029 at 5.2% CAGR
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Phosgene Market Outlook: What Size And CAGR Are Anticipated By 2025?
The size of the phosgene market has experienced substantial growth recently. It is anticipated to expand from $4.84 billion in 2024 to $5.1 billion in 2025, increasing at a compound annual growth rate (CAGR) of 5.5%. The rise experienced…
Methylene Diphenyl Diisocyanate (MDI)-Based Polyurethane Market to Record 5.1% C …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Methylene Diphenyl Diisocyanate (MDI)-Based Polyurethane Market Outlook: How is the Market Expected to Grow by 2025?
The market size of methylene diphenyl diisocyanate (MDI)-based polyurethane has been progressively increasing over the recent years. It's set to expand from a worth of $20.5 billion in 2024 to an estimated $21.21 billion…
More Releases for ARDS
Impact Of Increasing Pneumonia Prevalence On The Acute Respiratory Distress Synd …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Acute Respiratory Distress Syndrome (ARDS) Industry Market Size Be by 2025?
The market size for acute respiratory distress syndrome (ARDS) has experienced accelerated growth in the recent past. The market is expected to expand from $1.29 billion in 2024 to $1.42 billion in 2025, boasting a…
Acute Respiratory Distress Syndrome Market | ARDS Therapies, Clinical trials, AR …
As per DelveInsight, the Acute Respiratory Distress Syndrome Market is anticipated to grow immensely in the coming years owing to the launch of upcoming therapies and the increase in the incident population of ARDS in the 7MM.
DelveInsight's "Acute Respiratory Distress Syndrome Market Insights, Epidemiology, and Market Forecast 2034 [https://www.delveinsight.com/report-store/acute-respiratory-distress-syndrome-ards-market?utm_source=abnewswire&utm_medium=market&utm_campaign=kpr]" report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the Acute Respiratory Distress Syndrome market…
U.S. Acute Respiratory Distress Syndrome (ARDS) Market Size, Share, Industry, Fo …
The U.S. Acute Respiratory Distress Syndrome (ARDS) Market 2023 Report makes available the current and forthcoming technical and financial details of the industry. It is one of the most comprehensive and important additions to the Prudent Markets archive of market research studies. It offers detailed research and analysis of key aspects of the global U.S. Acute Respiratory Distress Syndrome (ARDS) market. This report explores all the key factors affecting the…
Acute Respiratory Distress Syndrome (ARDS) Market Size to Reach USD 18,559.22 Mi …
Data Bridge Market Research completed a qualitative study titled "Acute Respiratory Distress Syndrome (ARDS) Market" with 100+ market data tables, pie charts, graphs, and figures spread across Pages and an easy-to-grasp full analysis. The most up-to-date technology was used in conjunction with expert industry knowledge and practical, effective, and innovative solutions to develop this Acute Respiratory Distress Syndrome (ARDS) report. Market penetration-increasing tactics such as new product releases, geographical expansion,…
Acute Respiratory Distress Syndrome (ARDS) Market to Witness Growth by 2032, Est …
DelveInsight's "Acute Respiratory Distress Syndrome (ARDS) Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Acute Respiratory Distress Syndrome (ARDS), historical and forecasted epidemiology as well as the Acute Respiratory Distress Syndrome (ARDS) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom), and Japan.
The Acute Respiratory Distress Syndrome (ARDS) market report provides current treatment practices, emerging drugs, the market share of…
Europe Acute Respiratory Distress Syndrome (ARDS) Market
Europe acute respiratory distress syndrome (ARDS) market is expected to gain market growth in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 9.5% in the forecast period of 2022 to 2029 and is expected to reach USD 5,291.89 million by 2029.
The Europe acute respiratory distress syndrome (ARDS) marketing report presents data and information for actionable, most modern…
